Similarly, a significant increase was also observed in the expression of the splicing factor 3b subunit 1 (SF3B1), which is frequently mutated in Erα+ BCs and is associated with aberrant splicing and a poor prognosis in BC patients [54,55]. Here, ESR1 is linked to breast cancer.